Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

222.97
Delayed Data
As of Aug 21
 -1.02 / -0.46%
Today’s Change
184.50
Today|||52-Week Range
256.80
+6.17%
Year-to-Date
Will Conatus Key Candidate Emricasan Drive Long-Term Growth?
Aug 21 / Zacks.com - Paid Partner Content
Valeant Pharmaceuticals: Cramer's Top Takeaways
Aug 16 / TheStreet.com - Paid Partner Content
My Observations and Takeaways
Aug 21 / TheStreet.com - Paid Partner Content
The Market Is Not About Washington: Cramer's 'Mad Money' Recap (Wed 8/16/17)
Aug 16 / TheStreet.com - Paid Partner Content
Today's Trades
Aug 21 / TheStreet.com - Paid Partner Content
Shire Files Marketing Application for Lifitegrast in Europe
Aug 16 / Zacks.com - Paid Partner Content
Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain
Aug 17 / TheStreet.com - Paid Partner Content
Black, Jewish Goldman Executive Sues Firm Over Discriminatory Practices
Aug 16 / TheStreet.com - Paid Partner Content
PayPal, Marriott International, Randgold Resources: 'Mad Money' Lightning Round
Aug 16 / TheStreet.com - Paid Partner Content
Pressing AGN Again
Aug 16 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close223.99
Today’s open223.88
Day’s range222.41 - 225.24
Volume2,336,168
Average volume (3 months)2,173,786
Market cap$74.9B
Dividend yield1.26%
Data as of 08/21/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.19%
Earnings growth (next 5 years)+15.23%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.05

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.16-0.55%
ABTAbbott Laboratories+0.14+0.29%
LLYEli Lilly and Co+0.31+0.40%
NVONovo Nordisk+0.28+0.62%
Data as of 08/21/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$4.18
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts